Schwab's SCHY ETF, designed as the international counterpart to its popular SCHD U.S. dividend fund, faces strong competition from Vanguard's VYMI, Fidelity's FIDI, and BlackRock's IDV. Among these, Vanguard's VYMI stands out with a lower fee, broader market exposure including emerging markets, and superior recent returns, making it a better choice for investors seeking diversified international dividend income. Schwab's SCHY offers a tighter quality screen but lags in performance and yield compared to rivals. Investors should consider switching to VYMI for better diversification and returns, especially in tax-advantaged accounts, while those prioritizing yield might prefer BlackRock's IDV despite its higher fees.
SCHD trades at USD 33.92 with a 1-day gain of 0.24% as of Sep 18, 2026 04:31 WIB on Pluang. Its international rival VYMI is priced higher at USD 105.49 and gained 1.41% in the same period. VYMI also shows strong buying interest with 99% of orders as buys, compared to SCHD's 80% buy activity on Pluang.
The Schwab US Dividend Equity ETF (SCHD) has delivered strong price returns of 33% over the past year, yet its dividend income has grown only modestly by about 2%. The fund's top holdings, including Qualcomm, Texas Instruments, UnitedHealth, and Coca...
The Schwab U.S. Dividend Equity ETF (SCHD) has grown to nearly $95 billion in assets, attracting retirees with a 3.2% dividend yield from a portfolio of financially strong companies. Its top holdings include Qualcomm, UnitedHealth, Coca-Cola, and Tex...
The Schwab US Dividend Equity ETF (SCHD) is recommended as a Buy, primarily serving as a hedge against potential AI-driven market sell-offs rather than for its previous strengths in energy or rate-agnostic performance. Earlier gains were driven by en...
The Schwab US Dividend Equity ETF (SCHD) has outperformed the SPY index year-to-date, rising over 25% compared to SPY's approximate 12% gain. Key holdings such as DINO, APA, and TXN have delivered strong double- and triple-digit returns, boosting the...
